Trial | NCT00318162  Report issue

Title

Trial of Low-Dose Naltrexone for Children With Pervasive Developmental Disorder (PDD)
Randomized Double-Blind Trial of Low-Dose Naltrexone for Children With PDD

  • Phase

    Phase 1/Phase 2

  • Study Type

    Interventional

  • Status

    Unknown status

  • Intervention/Treatment

    naltrexone ...

  • Study Participants

    50
This study will examine the effects of low-dose naltrexone (LDN) on children with autistic spectrum disorders. The investigators hope to show a positive effect on social functioning and language.
Fifty children aged three to six years will be recruited for the study. They will be randomly assigned to receive either LDN or placebo for two months after which the treatment groups will be switched over. Assessments of functioning will be obtained from a video-taped play session, and by parent and teacher questionnaires at baseline, after two months and after four months.
Study Started
Apr 25
2006
Last Update
May 03
2006
Estimate

Drug low dose naltrexone

Criteria 

Inclusion Criteria:

Diagnosis of PDD
No Results Posted